BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.26.0//EN
X-ORIGINAL-URL:https://steven-kantor.com/
X-WR-CALNAME:Steven A Kantor
X-WR-CALDESC:
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-c831e9b5f6c9bab6b23c26c2dab2a29c@steven-kantor.com
DTSTART;TZID=America/New_York:20260710T080000
DTEND;TZID=America/New_York:20260710T180000
DTSTAMP:20260709T080034Z
CREATED:20260709
LAST-MODIFIED:20260710
PRIORITY:5
SEQUENCE:3
TRANSP:OPAQUE
SUMMARY:Life Sciences Collaborative – Boston Explores the Future of Robotic Neurosurgery
DESCRIPTION:The Life Sciences Collaborative – Boston Chapter held its June 30 meeting at Cushman & Wakefield in Boston, bringing together life sciences executives, entrepreneurs, investors, and innovators to discuss the latest advancements in medical technology.\nThe featured speaker was Gregory Fischer, Ph.D., Founder and CEO of AiM Medical Robotics, who shared the company’s vision for transforming neurosurgery through robotics and real-time imaging technology.\nAdvancing Precision in Neurosurgery\nDr. Fischer discussed how AiM Medical Robotics is developing MRI-compatible robotic technology designed to improve the treatment of functional brain disorders, including Parkinson’s disease and epilepsy.\nBy combining robotics, automation, and real-time imaging, the company’s platform is designed to enhance surgical precision, reduce the potential for human error, and shorten procedure times by as much as 50%. These advancements have the potential to improve both surgical efficiency and patient outcomes.\nFrom Research to Commercial Innovation\nIn addition to discussing the technology, Dr. Fischer shared the journey of building AiM Medical Robotics by translating NIH-funded research into a commercial medical technology company.\nHis presentation highlighted the challenges and opportunities involved in bringing breakthrough healthcare innovations from the research laboratory to clinical practice—a path that requires collaboration between researchers, entrepreneurs, investors, and industry partners.\nDriving Innovation Through Collaboration\nThe meeting reinforced the strength of the Boston life sciences ecosystem, where leading researchers, startup founders, investors, and industry executives regularly come together to exchange ideas and accelerate innovation.\nThe Life Sciences Collaborative continues to provide a valuable forum for showcasing emerging technologies and fostering the relationships that help move life-changing medical innovations from concept to patient care.\n\n
URL:https://steven-kantor.com/events/life-sciences-collaborative-boston-explores-the-future-of-robotic-neurosurgery/
CATEGORIES:Life Sciences Collaborative,LSC - Boston
ATTACH;FMTTYPE=image/png:https://steven-kantor.com/wp-content/uploads/2026/07/ChatGPT-Image-Jul-10-2026-01_49_48-PM-e1783706107732.png
END:VEVENT
END:VCALENDAR